Pillstats
Rx only · Tablet, Extended Release · Oral

Oxybutynin Chloride

Oxybutynin Chloride

18 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US51 NDCs
18 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC—
RxCUI (US)—
US makers18 labelers
Packages99
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 40 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.030$0.060$0.089$0.119Dec 2025Apr 2026Jul 2026
$0.097
Latest avg · Jul 22, 2026
-6%
Since Dec 17, 2025
18
Active US suppliers
25%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

58K116K173K231K2025 Q12025 Q22025 Q32025 Q42026 Q1
149K
Rx · 2026 Q1
6.0M
Units dispensed
-26%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it18 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Amneal Pharmaceuticals LLCunknown13SUPPLYING
Bryant Ranch Prepackrepackager12SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown10SUPPLYING
Rising Pharma Holdings, Inc.unknown7SUPPLYING
Advagen Pharma Ltdunknown6SUPPLYING
Ajanta Pharma USA Inc.unknown6SUPPLYING
Lannett Company, Inc.unknown6SUPPLYING
A-S Medication Solutionsunknown6SUPPLYING
Accord Healthcare Inc.unknown5SUPPLYING
AvKAREunknown5SUPPLYING
Proficient Rx LPunknown4SUPPLYING
AvPAKunknown3SUPPLYING
American Health Packagingunknown3SUPPLYING
Major Pharmaceuticalsunknown3SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown3SUPPLYING

+ 3 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 1, 2019
    RECALLRecall (Class III): Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 42291-634-01) and b) 500 tablets (NDC 42291…

    Failed Dissolution Specifications — Recalling firm: AVKARE Inc. — Nationwide.

  • Feb 21, 2019
    RECALLRecall (Class III): Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Ph…

    Failed Dissolution Specifications — Recalling firm: Lannett Company Inc. — Nationwide, including Puerto Rico.